Physician profile
Luis Geada
NPI 1649236837
$1,722.38
in general payments reported to CMS, 2019-2025
16 companies · $88.79 in 2025
The $88.79 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $721 · 2020: $42.20 · 2021: $125 · 2022: $119 · 2023: $282 · 2024: $345 · 2025: $88.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $715.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $427.57 | 2021-2025 | |
| Acell, INC. | $371.13 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $221.05 | 2019-2025 | Farxiga |
| Allergan, INC. | $125.00 | 2019 | |
| Medtronic Vascular, INC. | $120.55 | 2019 | |
| Intercept Pharmaceuticals, INC. | $114.30 | 2023 | Ocaliva |
| Karl Storz Endoscopy-America | $105.02 | 2024 | |
| Smith+Nephew, INC. | $59.07 | 2023 | Stravix, Grafix |
| Novo Nordisk INC | $56.16 | 2019-2020 | |
| Tela Bio, INC. | $33.85 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $21.28 | 2024 | Echelon; Endopath, Dermabond Prineo, Echelon Circular |
| Phathom Pharmaceuticals, INC. | $16.40 | 2024 | Voquezna |
| Lilly USA, LLC | $16.31 | 2023 | Mounjaro |
| Organogenesis INC. | $15.87 | 2023 | Puraply |
| Pfizer INC. | $15.34 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3.48 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Geada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.